After-Hours Stock Movers:Spectrum Pharmaceuticals (Nasdaq: SPPI) 27.7% LOWER; The FDA's Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with previously...
Source LinkAfter-Hours Stock Movers:Spectrum Pharmaceuticals (Nasdaq: SPPI) 27.7% LOWER; The FDA's Oncologic Drugs Advisory Committee (ODAC) met to review poziotinib for the treatment of patients with previously...
Source Link
Comments